LSL Pharma Group Expands with Virage Santé Buyout
Company Announcements

LSL Pharma Group Expands with Virage Santé Buyout

LSL Pharma Group Inc (TSE:LSL) has released an update.

LSL Pharma Group Inc. has successfully acquired Virage Santé, a manufacturer and marketer of natural health products, enhancing the company’s contract development and manufacturing capabilities. The $2.5 million cash purchase includes an 8,000 sq ft manufacturing plant and is expected to increase LSL Pharma’s revenues by 15-20% and expand its customer base. The acquisition aligns with LSL Pharma’s growth strategy to diversify services and strengthen its position in the pharmaceutical sector.

For further insights into TSE:LSL stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Canadian Auto-Generated NewsdeskLSL Pharma Group Announces Debenture Interest Payment
TipRanks Canadian Auto-Generated NewsdeskLSL Pharma Group Appoints New Auditor and Grants Stock Options
TipRanks Canadian Auto-Generated NewsdeskLSL Pharma Group Doubles Q2 Revenue, Slashes Loss
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App